Our data showed that DIS3L2 downregulation significantly reduced the viability of the most dedifferentiated CRC cell lines, SW480 and HCT116, but had little to no effect on the more differentiated Caco-2, HT-29 and non-transformed NCM460 cells. This evidence concerns the gene DIS3L2 and colorectal carcinoma.